As key Senate Democrats seek input on ways to design a public insurance option to cut health care costs, some prominent health care experts suggest a better way to improve federal health care ...

Medical associations are reiterating their recommendations that all adults and children over a certain age receive vaccinations against COVID-19, influenza and respiratory syncytial virus (RSV), which ...

States suing over the Medicaid work requirements interim final rule are narrowing their challenges to focus on alleged violations of the Administrative Procedure Act like the medically frail exemption ...

The health insurance industry is highlighting a new Health Affairs analysis that finds the No Surprises Act’s independent dispute resolution process resulted in $22.4 billion in costs from 2022 to ...

Amid Eli Lilly’s expanding legal fight with compounders and online peptide sellers marketing its experimental weight-loss drug retatrutide, FDA has sent another tranche of warning letters to five ...

Employees at HHS and most other federal workers would not get a raise next year for the second year in a row, under the pay adjustment plan President Donald Trump sent to Congress last week, angering ...

Just days after Solicitor General D. John Sauer conceded the Department of Justice could no longer defend FDA’s in-house civil penalties against tobacco retailers simply by invoking public health or ...

The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...

While stakeholders are telling CMS to go back to the drawing board on its proposed state-directed payments rule, their concerns go way beyond the proposed expansion of the SDP cap to flag structural ...

Democrats on the Senate Finance Committee are interested in establishing a subscription model to boost access to medicines like GLP-1s, one of many affordability policies lawmakers are considering ...

FDA is warning consumers taking compounded versions of GLP-1 medications that all vials should be discarded after 28 days, regardless of whether all doses have been used, saying holding onto vials for ...

FDA and the Securities and Exchange Commission (SEC) have entered for the first time into an information-sharing agreement that could give securities regulators greater access to non-public FDA ...